Home/Filings/4/0001225208-23-002832
4//SEC Filing

Hwang Angela 4

Accession 0001225208-23-002832

CIK 0000078003other

Filed

Feb 23, 7:00 PM ET

Accepted

Feb 24, 9:34 PM ET

Size

16.2 KB

Accession

0001225208-23-002832

Insider Transaction Report

Form 4
Period: 2023-02-22
Hwang Angela
Group President
Transactions
  • Exercise/Conversion

    Common Stock

    2023-02-22$30.17/sh+57,032$1,720,65567,027 total
  • Tax Payment

    Common Stock

    2023-02-22$42.38/sh8,041$340,77858,986 total
  • Award

    Stock Appreciation Rights

    2023-02-23+89,92089,920 total
    Exercise: $42.30From: 2030-02-23Exp: 2030-02-23Common Stock (89,920 underlying)
  • Tax Payment

    Common Stock

    2023-02-22$43.70/sh34,718$1,517,17724,268 total
  • Exercise/Conversion

    Stock Appreciation Rights

    2023-02-2257,0320 total
    Exercise: $30.17From: 2023-02-22Exp: 2023-02-22Common Stock (57,032 underlying)
  • Award

    Stock Appreciation Rights

    2023-02-23+103,320103,320 total
    Exercise: $42.30From: 2028-02-23Exp: 2028-02-23Common Stock (103,320 underlying)
Holdings
  • Common Stock

    (indirect: By Rule 16b-3 Plan)
    28,851
  • Common Stock

    (indirect: By Spouse)
    8,532
Footnotes (7)
  • [F1]The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
  • [F2]The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
  • [F3]The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
  • [F4]Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
  • [F5]The reporting person disclaims beneficial ownership of the shares held by spouse.
  • [F6]The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
  • [F7]The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.

Documents

1 file

Issuer

PFIZER INC

CIK 0000078003

Entity typeother

Related Parties

1
  • filerCIK 0001725474

Filing Metadata

Form type
4
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 9:34 PM ET
Size
16.2 KB